Making Sense of the COVID-19 Infodemic

Aug 13, 07:10 PM

Dr. Daniel Solomon---editor in chief of Arthritis and Rheumatology and chief of clinical sciences for rheumatology at Brigham and Women’s Hospital in Boston---describes the abundance of new research on hydroxychloroquine and cytokine storm syndrome as an "infodemic." In today’s edition of Overdrive, Dr. Solomon helps us make sense of the science.

Since the start of the COVID-19 pandemic early this year, there have been a number of studies published to test the effectiveness of hydroxychloroquine as a possible treatment. Observational studies have been published, case reports were published and randomized controlled trials were published showing that this tried and true treatment for some rheumatic conditions doesn’t work for COVID-19.

Dr. Daniel Solomon, who is editor in chief of Arthritis and Rheumatology and chief of clinical sciences for rheumatology at Brigham and Women’s Hospital in Boston, describes the abundance of new research on hydroxychloroquine and cytokine storm syndrome as an "infodemic."

In today’s edition of Overdrive, Dr. Solomon helps us make sense of the science.